Clinical trial
Effectiveness of Pramipexole for Treatment-Resistant Depression
NCT00231959 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00231959 |
|---|---|
| Title | Effectiveness of Pramipexole for Treatment-Resistant Depression |
| Official title | A Double-Blind Placebo-Controlled Trial of Adjunctive Pramipexole, a Dopamine Receptor Agonist, for Treatment Resistant Major Depressive Episodes |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Drug |
| Interventions | Pramipexole (Mirapex), Placebo |
| Enrollment | 65 |
| Start date | Sep 1, 2003 |
| Primary completion | Sep 1, 2007 |
| Completion | Apr 1, 2008 |
| First posted | Oct 4, 2005 |
| Last update posted | Apr 26, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: